DIAZASPIROALKANE DERIVATIVE

DIAZASPIROALKANE DERIVATIVE

PROBLEM TO BE SOLVED: To provide a new therapeutic agent for diabetes.SOLUTION: A diazaspiroalkane derivative which is a GPR 119 agonist, represented by general formula (II) (in the formula, R, Rand Reach represent a hydrogen atom, a halogen atom, a Calkyl group, a Calkoxy group, a Calkyl group subs...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ENDO TAKESHI, TAKAHASHI RIE, KUNIGAMI TOSHIHIRO, TANAKA HIROTO
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide a new therapeutic agent for diabetes.SOLUTION: A diazaspiroalkane derivative which is a GPR 119 agonist, represented by general formula (II) (in the formula, R, Rand Reach represent a hydrogen atom, a halogen atom, a Calkyl group, a Calkoxy group, a Calkyl group substituted with 1-3 halogen atoms, a Calkylsulfonyl group, or the like, T, U, Vand Weach represent Calkylene which may have a bond or a substituent, Brepresents Calkylene which may have C(=O) or a substituent, or the like, Yand Zeach represent Calkylene which may have a substituent, and R represents a hydrogen atom, a Calkyl group, or the like) or a pharmaceutically acceptable salt thereof is used as a therapeutic agent for diabetes.